Close

Cresset Targets Global Growth with New India HQ

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Insulated Pallet Protection in Temperature-Sensitive Pharmaceutical Shipping

In the pharmaceutical industry, products frequently require very specific...

Litmys and PharmaACE Establish Strategic Partnership for Market Projections

Life sciences consulting firms Litmys and PharmaACE have officially...

Blackstone Provides Up to $1.5 Billion for Pfizer’s Obesity Drug Candidate

Private equity firm Blackstone Life Sciences has agreed to...
- Advertisement -

Cresset, an innovative provider of solutions for Computational Drug Discovery and Development that accelerate research outcomes, is expanding its existing Asia Pacific presence by creating a new headquarters in Bangalore, one of India’s leading centers for biotechnology and pharmaceutical research.

This latest announcement consolidates Cresset’s position as a global player in the drug discovery space, and comes off the back of establishing a new facility in Boston earlier in the year.

From its origins in the UK, Cresset has grown into a drug discovery solutions company with a genuine global reach, with more than 60% of its revenues now coming from outside the UK. The company has experienced rapid growth in recent years, achieving an average year-on-year growth of over 25% and a significant increase in its employee headcount since 2020.

Cresset’s new India site will support the growing demands of Cresset’s APAC customer base, and increase its reach in a range of markets across the region, including South Korea, Japan, China, and Australasia.

Bangalore’s status as one of the top locations in the industry will enable Cresset to tap into the wealth of computational chemistry talent available on its doorstep, and be closer to its customer base. The new staff appointments in India will span a range of areas, including sales, support, and development.

Commenting on the new Indian HQ Cresset’s Chief Scientific Officer and co-Founder Dr. Mark Mackey said “Launching our new site in India marks a major milestone in our international growth and expansion as a company. The talent pool and centers of excellence available in the region will enable us to expand our existing service offering to clients and develop strong relationships through face-to-face contact on the ground.

“We already have a satellite office space in Bangalore, where a high proportion of our Indian staff are currently based. The new office will allow us to grow our overall business and gain access to grant funding in the Indian market”

As part of their work in India, Cresset’s Chief Scientific Officer Mark Mackey and Commercial Director David Bardsley will be attending the Indian Conference for Academics in Dehli on Tuesday 14th May 2024. The conference will cover a range of issues in the field of computational chemistry.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Latest stories

Related stories

Insulated Pallet Protection in Temperature-Sensitive Pharmaceutical Shipping

In the pharmaceutical industry, products frequently require very specific...

Litmys and PharmaACE Establish Strategic Partnership for Market Projections

Life sciences consulting firms Litmys and PharmaACE have officially...

Blackstone Provides Up to $1.5 Billion for Pfizer’s Obesity Drug Candidate

Private equity firm Blackstone Life Sciences has agreed to...

How Biopharmaceutical Research Is Shaping the Future of Cancer Treatment

Cancer is no longer viewed solely as a clinical...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »